Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1957 Jul 1;106(1):1–14. doi: 10.1084/jem.106.1.1

THE ROLE OF INTESTINAL BACTERIA IN THE DEVELOPMENT OF DIETARY CIRRHOSIS IN RATS

Alexander M Rutenburg 1, Edmund Sonnenblick 1, Irving Koven 1, H Arto Aprahamian 1, Leopold Reiner 1, Jacob Fine 1
PMCID: PMC2136738  PMID: 13439110

Abstract

Diffuse hepatic cirrhosis develops in rats on a choline-deficient diet within 300 days. Absorbable broad spectrum antibiotics added to the daily diet do not prevent the development of fatty infiltration, but they delay the development of cirrhosis for about 100 days more. Non-absorbable antibiotics added to the daily diet prevent the development of cirrhosis in most rats for as long as 750 days. The superiority of non-absorbable antibiotics to absorbable antibiotics excludes a systemic effect of the antibiotics and demonstrates that intestinal bacteria are largely, if not wholly, responsible for the cirrhosis in rats on a choline-deficient diet.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CARPENTER L. E. Effect of aureomycin on the growth of weaned pigs. Arch Biochem. 1950 Jul;27(2):469–471. [PubMed] [Google Scholar]
  2. Copeland D. H., Salmon W. D. The Occurrence of Neoplasms in the Liver, Lungs, and Other Tissues of Rats as a Result of Prolonged Choline Deficiency. Am J Pathol. 1946 Sep;22(5):1059–1079. [PMC free article] [PubMed] [Google Scholar]
  3. HARTROFT W. S. The sequence of pathologic events in the development of experimental fatty liver and cirrhosis. Ann N Y Acad Sci. 1954 May 10;57(6):633–645. doi: 10.1111/j.1749-6632.1954.tb36440.x. [DOI] [PubMed] [Google Scholar]
  4. KAGAN B. M., KREVSKY D., MILZER A., LOCKE M. Polymyxin B and polymyxin E; clinical and laboratory studies. J Lab Clin Med. 1951 Mar;37(3):402–414. [PubMed] [Google Scholar]
  5. LONGACRE A. B., WATERS R. M. Observation on absorption of bacitracin; blood levels following all administration. Surg Gynecol Obstet. 1951 Feb;92(2):213–216. [PubMed] [Google Scholar]
  6. LUCKEY T. D., REYNIERS J. A., GYORGY P., FORBES M. Germfree animals and liver necrosis. Ann N Y Acad Sci. 1954 May 10;57(6):932–935. doi: 10.1111/j.1749-6632.1954.tb36472.x. [DOI] [PubMed] [Google Scholar]
  7. Pulaski E. J., Baker H. J., Rosenberg M. L., Connell J. F. LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E. J Clin Invest. 1949 Sep;28(5 Pt 1):1028–1031. doi: 10.1172/JCI102134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SBOROV V. M., SUTHERLAND D. A. Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease. Gastroenterology. 1951 Aug;18(4):598–605. [PubMed] [Google Scholar]
  9. STANSLY P. G. The polymyxins; a review and assessment. Am J Med. 1949 Dec;7(6):807–818. doi: 10.1016/0002-9343(49)90419-2. [DOI] [PubMed] [Google Scholar]
  10. YESNER R., KUNKEL P. Preliminary observations on the effect of aureomycin, terramycin, tibione, combined tibione and streptomycin, and chloromycetin on the morphology of the liver in man. Yale J Biol Med. 1951 Feb;23(4):299–304. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES